Draft Reflection Paper on Use of AI/ML in Clinical Trial Design and Conduct

Summary

The EMA has released a draft reflection paper seeking stakeholder input on the use of artificial intelligence and machine learning technologies in clinical trial design, patient selection, and real-time data analysis. Consultation period open for 6 months. Addresses algorithmic transparency, validation requirements, and regulatory oversight.